Analyst firms · Morgan Stanley · BF.B
Morgan Stanley BF.B price target and rating history
Brown Forman Corporation (BF.B) · Consumer Staples
Morgan Stanley rates Brown Forman Corporation (BF.B) Underweight with a $23 price target, as of its latest action on Jun 5, 2026. It has published 5 rating actions on BF.B since March 2023, including 1 upgrade and 2 downgrades. Across 6 firms with a BF.B price target in the last 12 months, the median target is $27.50. Morgan Stanley's $23 is 16% below that.
- Current rating
- Underweight
- Price target
- $23
- Median target, all firms
- $27.50
- Actions on BF.B
- 5
Morgan Stanley price target on BF.B
Every Morgan Stanley rating on BF.B
- Jun 5, 2026
- Mar 6, 2025
- Jan 29, 2024
- Aug 23, 2023
- Mar 9, 2023
How other firms rate BF.B
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Equal Weight | $27 | Jun 25, 2026 |
| BofA Securities | Neutral | $28 | Jun 8, 2026 |
| Morgan Stanley | Underweight | $23 | Jun 5, 2026 |
| Citigroup | Neutral | $28 | Mar 27, 2026 |
| Bernstein | Mkt Perform | $29 | Mar 9, 2026 |
| BNP Paribas Exane | Underperform | $24 | Jan 16, 2026 |
Questions about Morgan Stanley and BF.B
- What is Morgan Stanley's price target for BF.B?
- Morgan Stanley's latest stated price target for Brown Forman Corporation (BF.B) is $23, from its action on Jun 5, 2026.
- What is Morgan Stanley's rating on BF.B?
- Morgan Stanley rates BF.B Underweight, a bearish rating, as of Jun 5, 2026.
- When did Morgan Stanley last change its view on BF.B?
- On Jun 5, 2026, Morgan Stanley resumes coverage at Underweight, price target $23.
- How does Morgan Stanley's BF.B target compare with other analysts?
- Across 6 firms with a BF.B price target in the last 12 months, the median target is $27.50. Morgan Stanley's $23 is 16% below that.
More BF.B rating histories
All Morgan Stanley ratingsBF.B news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.